Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery

被引:119
作者
Cheng, Yiyun [1 ,2 ,3 ]
Wang, Jinrong [1 ]
Rao, Tingling [1 ]
He, Xiaoxiao [1 ]
Xu, Tongwen [1 ]
机构
[1] Univ Sci & Technol China, Dept Chem, Lab Funct Membranes, Hefei 230026, Anhui, Peoples R China
[2] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China
[3] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2008年 / 13卷
关键词
dendrimers; nanocarrier; non-steroidal anti-inflammatory drugs; anti-microbial drugs; anti-viral drugs; anti-cancer drugs; review;
D O I
10.2741/2774
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dendrimers are new artificial macromolecules which have the structure like a tree. They are hyperbranched and monodisperse three-dimensional molecules with defined molecular weights, large numbers of functional groups on the surface and well-established host-guest entrapment properties. Recently, dendrimers have successfully proved themselves as promising nanocarriers for drug delivery because they can render drug molecules a greater water-solubility, bioavailability, and biocompatibility. In this review, recent progress in the pharmaceutical applications of dendrimers as delivery systems for drugs, paticularly, the non-steroidal anti-inflammatory, anti-microbial/anti-viral and potent anticancer drugs is discussed. Three possible interaction mechanisms between dendrimers and drug molecules are presented. In addition, the pharmacodynamic and pharmacokinetic properties of both dendrimer/drug complex and dendrimer-drug conjugation after their administration to animals are evaluated.
引用
收藏
页码:1447 / 1471
页数:25
相关论文
共 144 条
[71]  
Makiko F, 2000, INT J PHARMACEUT, V205, P117
[72]   Dendrimer-platinate: a novel approach to cancer chemotherapy [J].
Malik, N ;
Evagorou, EG ;
Duncan, R .
ANTI-CANCER DRUGS, 1999, 10 (08) :767-776
[73]   Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies [J].
Man Na ;
Cheng Yiyun ;
Xu Tongwen ;
Ding Yang ;
Wang Xiaomin ;
Li Zhenwei ;
Chen Zhichao ;
Huang Guanyi ;
Shi Yunyu ;
Wen Longping .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2006, 41 (05) :670-674
[74]  
Marie R. G., 1996, AM J MED, V100, p31S
[75]  
MARIE RG, 1998, AM J MED, V104, pS23
[76]   Dendrimers as drugs: Discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention [J].
McCarthy, Tom D. ;
Karellas, Peter ;
Henderson, Scott A. ;
Giannis, Michael ;
O'Keefe, David F. ;
Heery, Graharn ;
Paull, Jeremy R. A. ;
Matthews, Barry R. ;
Holan, George .
MOLECULAR PHARMACEUTICS, 2005, 2 (04) :312-318
[77]   Polyamidoamine Starburst® dendrimers as solubility enhancers [J].
Milhem, OM ;
Myles, C ;
McKeown, NB ;
Attwood, D ;
D'Emanuele, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 197 (1-2) :239-241
[78]   Dendrimer-encapsulated camptothecins:: Increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro [J].
Morgan, Meredith T. ;
Nakanishi, Yuka ;
Kroll, David J. ;
Griset, Aaron P. ;
Carnahan, Michael A. ;
Wathier, Michel ;
Oberlies, Nicholas H. ;
Manikumar, Govindarajan ;
Wani, Mansukh C. ;
Grinstaff, Mark W. .
CANCER RESEARCH, 2006, 66 (24) :11913-11921
[79]   Dendritic supramolecular assemblies for drug delivery [J].
Morgan, MT ;
Carnahan, MA ;
Finkelstein, S ;
Prata, CAH ;
Degoricija, L ;
Lee, SJ ;
Grinstaff, MW .
CHEMICAL COMMUNICATIONS, 2005, (34) :4309-4311
[80]  
Mukesh S., 2002, CHEM-BIOL INTERACT, V142, P155